Medicine and Dentistry
Observational Study
100%
Biological Marker
78%
Antibiotics
78%
COVID-19 Vaccine
67%
Adeno Associated Virus 2
63%
Cohort Analysis
63%
Antibiotic Therapy
57%
Severe Acute Respiratory Syndrome Coronavirus 2
49%
COVID-19 Vaccination
47%
Acute Hepatitis
36%
Protocol Compliance
31%
Informed Consent
31%
Sweat Test
31%
Independent Reviewer
31%
Physical Development
31%
Seasonal Variation
31%
Kolmogorov Smirnov Test
31%
Newborn Screening
31%
Pathogen
31%
Cystic Fibrosis
31%
Emergency Care
31%
Antiinfective Agent
31%
Enzyme Linked Immunosorbent Assay
31%
Bacterial Pneumonia
31%
Patient Assessment
31%
Oxygen Therapy
31%
Comorbidity
31%
Autoantibodies
31%
Serositis
31%
Patient Referral
31%
Myocarditis
31%
Procalcitonin
31%
COVID-19
29%
Booster Dose
25%
Partial Least Squares Regression
25%
Immunoreactive Trypsinogen
22%
Clinical Decision Making
21%
Logistic Regression Analysis
21%
Feature Extraction
18%
Human Herpesvirus 6
15%
Human Leukocyte Antigen
15%
Prospective Cohort Study
14%
Neonates
13%
Liquid Chromatography-Mass Spectrometry
12%
Sepsis
11%
Immunoglobulin G
11%
T Cell
10%
Human Adenovirus C
10%
Effect Size
10%
Disease Predisposition
10%
Pharmacology, Toxicology and Pharmaceutical Science
COVID-19 Vaccine
99%
Cohort Study
94%
Biological Marker
94%
SARS Coronavirus
81%
Antibiotics
78%
Observational Study
68%
Antibacterial Therapy
31%
Adeno Associated Virus 2
31%
Comorbidity
31%
Infectious Agent
31%
Antiinfective Agent
31%
Enzyme-Linked Immunosorbent Assay
31%
Bacterial Pneumonia
31%
Autoantibodies
31%
Inflammation
31%
Myocarditis
31%
Procalcitonin
31%
Syndrome
21%
Prospective Cohort Study
18%
Bronchiolitis
15%
Leukocyte Antigen
15%
Respiratory Virus
15%
Sepsis
11%
Immunoglobulin G
11%
Human Adenovirus C
10%
Disease Predisposition
10%
HIV
10%
Infectious Complication
10%
Acquired Immune Deficiency Syndrome
10%
Immune Deficiency
10%
Myocardial Disease
9%
Penicillin
9%
Immunoglobulin M
9%
Escherichia coli
7%
Streptococcus Group A
7%
Enterovirus
7%
Influenza B
7%
Influenza A
7%
Immunoglobulin A
6%
Effectiveness Study
6%
Neutrophil Gelatinase Associated Lipocalin
6%
Acute Hepatitis
5%
Helper Virus
5%
Mixed Infection
5%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
57%
SARS Coronavirus
36%
Glycosylation
31%
Autoantibodies
31%
Proteome
31%
Feature Extraction
31%
Adeno Associated Virus 2
31%
Glycopeptide
31%
Cohort Study
31%
Infectious Agent
31%
Immunoglobulin G
31%
Newborn Screening
31%
Immunoreactive Trypsinogen
31%
Cystic Fibrosis
31%
Immunoglobulin M
26%
Glycoproteomics
21%
Liquid Chromatography-Mass Spectrometry
21%
Immunoglobulin A
21%
Human Herpesvirus 6
15%
Multiplex Ligation-Dependent Probe Amplification
12%
Patient Coding
10%
Fluorescein Isothiocyanate
10%
Posttranslational Modification
10%
Protein Expression
10%
Genetic Disorder
6%
DNA Analysis
6%
Gene Sequence
6%
Enzyme
6%
Dideoxynucleotide Sequencing
6%
Immunoassay
6%
Immunoglobulin Variable Region
5%
Immunofluorescence
5%
Adenoviridae
5%
T Cell
5%
